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OBJECTIVE: Compare the resource use between IBS
patients and non-IBS subjects (controls), in order to esti-
mate the burden of IBS. METHODS: Observational,
prospective study including a sample of 455 IBS patients,
meeting Rome II criteria, and 69 controls. The controls
were selected from those subjects who had attended a
health centre with a relative due to digestive problems
(excluding IBS). Both samples were selected from the 
consulting rooms of 86 Spanish gastroenterologists and
physicians. Patients and controls attended a total of ﬁve
visits at three-month intervals, making a total follow-up
period of one year. During the ﬁrst month after each visit
patients completed a diary including information about
resource use. Indirect resources and drugs use were reg-
istered in the patients’ diary and other direct resources
were registered in follow-up medical controls. RESULTS:
The results presented are preliminary and corresponding
to prospective information obtained from the ﬁrst 3
months’ follow-up. The patients mean (SD) age was 43
(14) years and 76.5% were female. Patients and controls
were of the same age and gender. 52.6% of IBS patients
and 29% of controls visited a clinic at least ones (p <
0.01), 2% of patients were hospitalised and 14.2% of
patients visited an emergency ward at least ones. The cost
associated with resources used was almost three times
higher in patients than in controls (p < 0.01). In terms of
indirect resources, 35.8% of patients and 20% of con-
trols experienced limited or reduced performance at work
during the month following the baseline visit (p < 0.05).
The mean cost associated with absence from work at one
month was also higher for patients (€100.34) than for
controls (€37.12) (p < 0.01). CONCLUSIONS: IBS is
associated with an important burden in terms of direct
and indirect costs, IBS patients using more health
resources and experiencing a higher productivity loss.
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OBJECTIVE: Using a Delphi panel method, this study
determined and evaluated the clinical treatment patterns
of moderate-to-severe gastrointestinal (GI) events associ-
ated with NSAIDs in Japan. METHODS: Two resource
utilization questionnaires were originally developed in
English for a similar survey in the US and Europe (one
for GI events requiring hospitalization and another for
those not requiring hospitalization). The questionnaires
were translated and culturally adapted for Japan and a
pilot test was conducted. For the full survey, a Delphi-
panel method was used. RESULTS: The pilot test of 
the translated/culturally-adapted questionnaires indicated
that the instruments could feasibly be adapted for use in
Japan. Missing data was only 4% in the pilot test. For
the Delphi panel, 30 specialists were contacted to parti-
cipate (10 rheumatologists and 20 gastroenterologists).
Physicians were interviewed separately face-to-face,
answers were summarized across all participants and the
summary results were presented to each participant at 
a second face-to-face meeting. Participants could then
modify their original answers. Average resources and
costs required for the treatment and follow-up of GI
events will be summarized. CONCLUSION: A lack of
observational databases in Japan makes identiﬁcation of
treatment patterns and thus resource utilization estimates
quite difﬁcult. Interviewing experts about their treatment
patterns using a Delphi panel approach appears to be a
feasible option in Japan; individual face-to-face inter-
views are recommended. Cultural adaptation of ques-
tionnaires (originally developed for use outside of Japan)
was necessary as the design of questionnaires and the
structure of questions in Japan is somewhat different.
Additionally, modiﬁcation of the target specialist physi-
cians was necessary due to the different referral patterns
found in Japan.
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OBJECTIVES: To evaluate the cost-effectiveness of three
treatment strategies for maintenance therapy of gastroe-
sophageal reﬂux disease (GERD) from the perspective of
a public health organization in Hong Kong. METHODS:
A Markov model was designed to simulate, over 12
months, the resource utilization and clinical outcomes of
GERD patients with healed esophagitis associated with
three treatment alternatives: Standard-dose H2-receptor
antagonist (H2RA), low-dose proton-pump inhibitor
(PPI) and standard-dose PPI. Patients who experienced
relapse of GERD on H2RA or low-dose PPI would be
stepped-up to standard-dose PPI. Relapse occurred during
maintenance therapy with standard-dose PPI would be
treated by high-dose PPI. The probabilities of relapse
were derived from literature. Resource utilization for
maintenance and active treatment of GERD were
